2014 Q2 Form 10-Q Financial Statement
#000094664414000008 Filed on May 09, 2014
Income Statement
| Concept | 2014 Q2 | 2014 Q1 | 2013 Q1 |
|---|---|---|---|
| Revenue | $36.00K | $76.00K | $42.00K |
| YoY Change | 0.0% | 80.95% | -41.67% |
| Cost Of Revenue | $294.0K | $323.0K | $191.0K |
| YoY Change | -53.7% | 69.11% | -31.79% |
| Gross Profit | -$258.0K | -$247.0K | -$149.0K |
| YoY Change | -56.93% | 65.77% | -28.37% |
| Gross Profit Margin | -716.67% | -325.0% | -354.76% |
| Selling, General & Admin | $2.500M | $2.540M | $2.080M |
| YoY Change | 37.36% | 22.12% | 11.23% |
| % of Gross Profit | |||
| Research & Development | $2.330M | $2.326M | $2.336M |
| YoY Change | 0.52% | -0.43% | 40.3% |
| % of Gross Profit | |||
| Depreciation & Amortization | $270.0K | $167.0K | $179.0K |
| YoY Change | 3.85% | -6.7% | 20.13% |
| % of Gross Profit | |||
| Operating Expenses | $2.330M | $2.326M | $2.336M |
| YoY Change | 0.52% | -0.43% | 40.3% |
| Operating Profit | -$5.085M | -$5.112M | -$4.562M |
| YoY Change | 7.41% | 12.06% | 21.75% |
| Interest Expense | $130.0K | $0.00 | $49.00K |
| YoY Change | -62.86% | -100.0% | 345.45% |
| % of Operating Profit | |||
| Other Income/Expense, Net | $0.00 | $0.00 | $176.0K |
| YoY Change | -100.0% | -100.0% | -32.82% |
| Pretax Income | -$4.960M | -$3.840M | -$3.610M |
| YoY Change | 15.89% | 6.37% | 56.28% |
| Income Tax | $0.00 | $0.00 | $0.00 |
| % Of Pretax Income | |||
| Net Earnings | -$4.956M | -$3.836M | -$3.611M |
| YoY Change | 15.71% | 6.23% | 56.46% |
| Net Earnings / Revenue | -13766.67% | -5047.37% | -8597.62% |
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$14.17M | -$11.64M | -$11.28M |
| COMMON SHARES | |||
| Basic Shares Outstanding | 183.9M shares | 179.3M shares | |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2014 Q2 | 2014 Q1 | 2013 Q1 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $20.21M | $21.55M | $37.84M |
| YoY Change | -37.85% | -43.05% | 17.55% |
| Cash & Equivalents | $2.617M | $4.105M | $1.588M |
| Short-Term Investments | $17.60M | $17.45M | $36.25M |
| Other Short-Term Assets | $250.0K | $330.0K | $290.0K |
| YoY Change | -30.56% | 13.79% | -17.14% |
| Inventory | $0.00 | $0.00 | $450.0K |
| Prepaid Expenses | $246.0K | $333.0K | $293.0K |
| Receivables | |||
| Other Receivables | |||
| Total Short-Term Assets | $20.46M | $21.89M | $38.58M |
| YoY Change | -37.78% | -43.27% | 14.69% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $4.845M | $4.890M | $5.131M |
| YoY Change | -2.93% | -4.7% | -37.12% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $134.0K | $136.0K | $65.00K |
| YoY Change | -1.47% | 109.23% | -7.14% |
| Total Long-Term Assets | $13.09M | $13.12M | $13.08M |
| YoY Change | -1.28% | 0.34% | 43.87% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $20.46M | $21.89M | $38.58M |
| Total Long-Term Assets | $13.09M | $13.12M | $13.08M |
| Total Assets | $33.55M | $35.01M | $51.66M |
| YoY Change | -27.29% | -32.23% | 20.9% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $1.471M | $1.217M | $1.665M |
| YoY Change | 52.12% | -26.91% | -32.32% |
| Accrued Expenses | $2.659M | $1.740M | $1.269M |
| YoY Change | 47.31% | 37.12% | 164.38% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $7.050M |
| YoY Change | -100.0% | -100.0% | 209.21% |
| Long-Term Debt Due | $30.00K | $30.00K | $40.00K |
| YoY Change | -25.0% | -25.0% | -20.0% |
| Total Short-Term Liabilities | $4.161M | $2.988M | $10.03M |
| YoY Change | -57.79% | -70.2% | 67.69% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $10.00K | $20.00K | $50.00K |
| YoY Change | -75.0% | -60.0% | -44.44% |
| Other Long-Term Liabilities | $10.00K | $10.00K | $210.0K |
| YoY Change | -90.0% | -95.24% | -60.38% |
| Total Long-Term Liabilities | $20.00K | $30.00K | $260.0K |
| YoY Change | -85.71% | -88.46% | -58.06% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $4.161M | $2.988M | $10.03M |
| Total Long-Term Liabilities | $20.00K | $30.00K | $260.0K |
| Total Liabilities | $4.181M | $3.017M | $10.28M |
| YoY Change | -58.19% | -70.65% | 55.74% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$269.1M | -$264.2M | -$247.7M |
| YoY Change | 6.8% | 6.64% | |
| Common Stock | $298.4M | $296.2M | $289.1M |
| YoY Change | 3.18% | 2.47% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $29.37M | $31.99M | $41.38M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $33.55M | $35.01M | $51.66M |
| YoY Change | -27.29% | -32.23% | 20.9% |
Cashflow Statement
| Concept | 2014 Q2 | 2014 Q1 | 2013 Q1 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$4.956M | -$3.836M | -$3.611M |
| YoY Change | 15.71% | 6.23% | 56.46% |
| Depreciation, Depletion And Amortization | $270.0K | $167.0K | $179.0K |
| YoY Change | 3.85% | -6.7% | 20.13% |
| Cash From Operating Activities | -$3.310M | -$2.895M | -$5.851M |
| YoY Change | -12.43% | -50.52% | 251.41% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$250.0K | $65.00K | $244.0K |
| YoY Change | -32.43% | -73.36% | -84.28% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $10.00K | -$40.00K | $5.530M |
| YoY Change | -99.74% | -100.72% | 72.81% |
| Cash From Investing Activities | -$240.0K | -$177.0K | $5.240M |
| YoY Change | -106.84% | -103.38% | 218.93% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $6.385M | $0.00 | |
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 2.070M | $6.374M | -$13.00K |
| YoY Change | -10450.0% | -49130.77% | -102.28% |
| NET CHANGE | |||
| Cash From Operating Activities | -3.310M | -$2.895M | -$5.851M |
| Cash From Investing Activities | -240.0K | -$177.0K | $5.240M |
| Cash From Financing Activities | 2.070M | $6.374M | -$13.00K |
| Net Change In Cash | -1.480M | $3.302M | -$624.0K |
| YoY Change | 410.34% | -629.17% | -214.08% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$3.310M | -$2.895M | -$5.851M |
| Capital Expenditures | -$250.0K | $65.00K | $244.0K |
| Free Cash Flow | -$3.060M | -$2.960M | -$6.095M |
| YoY Change | -10.26% | -51.44% | 89.46% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2013Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
|
0 | USD |
| CY2013Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1271000 | USD |
| CY2014Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1217000 | USD |
| CY2014Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1740000 | USD |
| CY2013Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1228000 | USD |
| CY2014Q1 | us-gaap |
Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
|
1740000 | USD |
| CY2013Q4 | us-gaap |
Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
|
1228000 | USD |
| CY2014Q1 | us-gaap |
Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
|
220000 | USD |
| CY2013Q4 | us-gaap |
Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
|
270000 | USD |
| CY2013Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
4334000 | USD |
| CY2014Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
4501000 | USD |
| CY2014Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-93000 | USD |
| CY2013Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-114000 | USD |
| CY2014Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
296058000 | USD |
| CY2013Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
289563000 | USD |
| CY2013Q1 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
4000 | USD |
| CY2014Q1 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
165000 | USD |
| CY2013Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
36051415 | shares |
| CY2014Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
72026419 | shares |
| CY2013Q4 | us-gaap |
Assets
Assets
|
31867000 | USD |
| CY2014Q1 | us-gaap |
Assets
Assets
|
35010000 | USD |
| CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
18552000 | USD |
| CY2014Q1 | us-gaap |
Assets Current
AssetsCurrent
|
21887000 | USD |
| CY2014Q1 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
17449000 | USD |
| CY2013Q4 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
17391000 | USD |
| CY2014Q1 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
17542000 | USD |
| CY2013Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
17504000 | USD |
| CY2013 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses
|
0 | USD |
| CY2014Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses
|
0 | USD |
| CY2013 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Aggregate Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses
|
229000 | USD |
| CY2014Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Aggregate Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses
|
93000 | USD |
| CY2013Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
|
12460000 | USD |
| CY2014Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
|
17449000 | USD |
| CY2013 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses
|
229000 | USD |
| CY2014Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses
|
93000 | USD |
| CY2013Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
|
12460000 | USD |
| CY2014Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
|
17449000 | USD |
| CY2014Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
|
0 | USD |
| CY2014Q1 | us-gaap |
Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
|
17449000 | USD |
| CY2013Q4 | us-gaap |
Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
|
17391000 | USD |
| CY2014Q1 | us-gaap |
Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
|
0 | USD |
| CY2013 | us-gaap |
Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
|
116000 | USD |
| CY2014Q1 | us-gaap |
Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
|
93000 | USD |
| CY2013 | us-gaap |
Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
|
229000 | USD |
| CY2014Q1 | us-gaap |
Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
|
0 | USD |
| CY2013Q4 | us-gaap |
Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
|
0 | USD |
| CY2014Q1 | us-gaap |
Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
|
31000 | USD |
| CY2013Q4 | us-gaap |
Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
|
33000 | USD |
| CY2014Q1 | us-gaap |
Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
|
15000 | USD |
| CY2013Q4 | us-gaap |
Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
|
23000 | USD |
| CY2014Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
4105000 | USD |
| CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
803000 | USD |
| CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2212000 | USD |
| CY2013Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1588000 | USD |
| CY2014Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
3302000 | USD |
| CY2013Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-624000 | USD |
| CY2013Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2014Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2014Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
350000000 | shares |
| CY2014Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
350000000 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
168660370 | shares |
| CY2014Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
183285228 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
168660370 | shares |
| CY2014Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
183285228 | shares |
| CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
168000 | USD |
| CY2014Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
183000 | USD |
| CY2013Q1 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-3575000 | USD |
| CY2014Q1 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-3815000 | USD |
| CY2014Q1 | us-gaap |
Construction In Progress Gross
ConstructionInProgressGross
|
7107000 | USD |
| CY2013Q4 | us-gaap |
Construction In Progress Gross
ConstructionInProgressGross
|
7046000 | USD |
| CY2013Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
191000 | USD |
| CY2014Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
323000 | USD |
| CY2013Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
4604000 | USD |
| CY2014Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
5188000 | USD |
| CY2013Q1 | us-gaap |
Depreciation
Depreciation
|
179000 | USD |
| CY2014Q1 | us-gaap |
Depreciation
Depreciation
|
167000 | USD |
| CY2013Q1 | us-gaap |
Derivative Gain On Derivative
DerivativeGainOnDerivative
|
89000 | USD |
| CY2014Q1 | us-gaap |
Derivative Gain On Derivative
DerivativeGainOnDerivative
|
0 | USD |
| CY2014Q1 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
14000 | USD |
| CY2013Q4 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
14000 | USD |
| CY2014Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.02 | |
| CY2013Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.02 | |
| CY2014Q1 | us-gaap |
Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
|
1002000 | USD |
| CY2013Q4 | us-gaap |
Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
|
378000 | USD |
| CY2014Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
261000 | USD |
| CY2013Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
208000 | USD |
| CY2014Q1 | us-gaap |
Fair Value Assumptions Expected Dividend Payments
FairValueAssumptionsExpectedDividendPayments
|
0.00 | |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
1080000 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
990000 | USD |
| CY2013Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2077000 | USD |
| CY2014Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2539000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-16000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-358000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
512000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-2126000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-25000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-29000 | USD |
| CY2013 | us-gaap |
Interest Costs Capitalized
InterestCostsCapitalized
|
143000 | USD |
| CY2014Q1 | us-gaap |
Interest Expense
InterestExpense
|
0 | USD |
| CY2013Q1 | us-gaap |
Interest Expense
InterestExpense
|
49000 | USD |
| CY2013Q1 | us-gaap |
Interest Expense Lessee Assets Under Capital Lease
InterestExpenseLesseeAssetsUnderCapitalLease
|
5000 | USD |
| CY2014Q1 | us-gaap |
Interest Expense Lessee Assets Under Capital Lease
InterestExpenseLesseeAssetsUnderCapitalLease
|
3000 | USD |
| CY2013Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
0 | USD |
| CY2012Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
453000 | USD |
| CY2014Q1 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
0 | USD |
| CY2014Q1 | us-gaap |
Liabilities
Liabilities
|
3017000 | USD |
| CY2013Q4 | us-gaap |
Liabilities
Liabilities
|
2569000 | USD |
| CY2014Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
35010000 | USD |
| CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
31867000 | USD |
| CY2014Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2988000 | USD |
| CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2532000 | USD |
| CY2014Q1 | us-gaap |
Line Of Credit Facility Increase Accrued Interest
LineOfCreditFacilityIncreaseAccruedInterest
|
130000 | USD |
| CY2014Q1 | us-gaap |
Line Of Credit Facility Initiation Date1
LineOfCreditFacilityInitiationDate1
|
2011-07-26 | |
| CY2014Q1 | us-gaap |
Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
|
0.025 | |
| CY2014Q1 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis Of Presentation</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements include the financial statements of Hemispherx Biopharma, Inc. and its wholly-owned subsidiaries. The Company has </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;"> domestic subsidiaries: BioPro Corp., BioAegean Corp. and Core Biotech Corp., all of which are incorporated in Delaware and are dormant. The Company’s foreign subsidiary, Hemispherx Biopharma Europe N.V./S.A., established in Belgium in 1998, has minimal activity. All significant intercompany balances and transactions have been eliminated in consolidation. Certain items in these financial statements have been reclassified to conform to the current year presentation. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the opinion of Management, all adjustments necessary for a fair presentation of such consolidated financial statements have been included. Such adjustments consist of normal recurring items. Interim results are not necessarily indicative of results for a full year.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The interim consolidated financial statements and notes thereto are presented as permitted by the Securities and Exchange Commission (“SEC”), and do not contain certain information which will be included in the Company’s annual consolidated financial statements and notes thereto.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements for the years ended December 31, 2013 and 2012, contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.</font></div></div> | |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-13000 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
6374000 | USD |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
5240000 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-177000 | USD |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-5851000 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2895000 | USD |
| CY2013Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4562000 | USD |
| CY2014Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5112000 | USD |
| CY2014Q1 | us-gaap |
Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
|
481000 | USD |
| CY2013Q4 | us-gaap |
Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
|
529000 | USD |
| CY2013Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
136000 | USD |
| CY2014Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
136000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
36000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
21000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-3815000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
0 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
9000 | USD |
| CY2014Q1 | us-gaap |
Other Interest And Dividend Income
OtherInterestAndDividendIncome
|
153000 | USD |
| CY2013Q1 | us-gaap |
Other Interest And Dividend Income
OtherInterestAndDividendIncome
|
181000 | USD |
| CY2014Q1 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
75000 | USD |
| CY2013Q1 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
46000 | USD |
| CY2013Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
0 | USD |
| CY2014Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
37000 | USD |
| CY2014Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
65000 | USD |
| CY2013Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
244000 | USD |
| CY2013Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2014Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2014Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
| CY2014Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2014Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2014Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2013Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
358000 | USD |
| CY2014Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
333000 | USD |
| CY2013Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD |
| CY2014Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
6385000 | USD |
| CY2013Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
5530000 | USD |
| CY2014Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
0 | USD |
| CY2013Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-3611000 | USD |
| CY2014Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-3836000 | USD |
| CY2014Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
9391000 | USD |
| CY2013Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
9387000 | USD |
| CY2014Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4890000 | USD |
| CY2013Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
5053000 | USD |
| CY2013Q1 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
13000 | USD |
| CY2014Q1 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
11000 | USD |
| CY2014Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2326000 | USD |
| CY2013Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2336000 | USD |
| CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-260319000 | USD |
| CY2014Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-264155000 | USD |
| CY2014Q1 | us-gaap |
Revenues
Revenues
|
76000 | USD |
| CY2013Q1 | us-gaap |
Revenues
Revenues
|
42000 | USD |
| CY2013Q1 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
42000 | USD |
| CY2014Q1 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
76000 | USD |
| CY2013Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Method Used
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsMethodUsed
|
Black-Scholes-Merton | |
| CY2014Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
6385000 | USD |
| CY2014Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
88000 | USD |
| CY2013Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
121000 | USD |
| CY2014Q1 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
88000 | USD |
| CY2013Q1 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
121000 | USD |
| CY2013Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
29298000 | USD |
| CY2014Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
31993000 | USD |
| CY2014Q1 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
21000 | USD |
| CY2013Q1 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
45000 | USD |
| CY2013Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
166806729 | shares |
| CY2014Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
176730956 | shares |
| CY2013Q4 | heb |
Accrued Production Cost
AccruedProductionCost
|
51000 | USD |
| CY2014Q1 | heb |
Accrued Production Cost
AccruedProductionCost
|
37000 | USD |
| CY2013Q4 | heb |
Availableforsale Securities Continuous Unrealized Loss Position Numberof Securitiesin Loss Position
AvailableforsaleSecuritiesContinuousUnrealizedLossPositionNumberofSecuritiesinLossPosition
|
1 | investment |
| CY2014Q1 | heb |
Availableforsale Securities Continuous Unrealized Loss Position Numberof Securitiesin Loss Position
AvailableforsaleSecuritiesContinuousUnrealizedLossPositionNumberofSecuritiesinLossPosition
|
2 | investment |
| CY2014Q1 | heb |
Funds Received From Sale Of Income Tax Net Operating Losses
FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses
|
1126000 | USD |
| CY2013Q1 | heb |
Funds Received From Sale Of Income Tax Net Operating Losses
FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses
|
686000 | USD |
| CY2014Q1 | heb |
Funds Received From Sale Of Income Tax Net Operating Losses
FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses
|
1126000 | USD |
| CY2014Q1 | heb |
Inventory Production
InventoryProduction
|
0 | USD |
| CY2013 | heb |
Inventory Production
InventoryProduction
|
0 | USD |
| CY2014Q1 | heb |
Inventory Spoilage
InventorySpoilage
|
0 | USD |
| CY2013 | heb |
Inventory Spoilage
InventorySpoilage
|
453000 | USD |
| CY2013Q1 | heb |
Issuance Of Common Stock For Accounts Payable And Accrued Expenses
IssuanceOfCommonStockForAccountsPayableAndAccruedExpenses
|
134000 | USD |
| CY2014Q1 | heb |
Issuance Of Common Stock For Accounts Payable And Accrued Expenses
IssuanceOfCommonStockForAccountsPayableAndAccruedExpenses
|
38000 | USD |
| CY2014Q1 | heb |
Margin Account Loan Liability
MarginAccountLoanLiability
|
0 | USD |
| CY2014Q1 | heb |
Number Of Domestic Subsidiaries
NumberOfDomesticSubsidiaries
|
3 | subsidiary |
| CY2014Q1 | heb |
Reduction In Wells Fargo Base Rate Percentage
ReductionInWellsFargoBaseRatePercentage
|
0.0275 | |
| CY2014Q1 | heb |
Stock Issued For Settlement Of Accounts Payable
StockIssuedForSettlementOfAccountsPayable
|
37000 | USD |
| CY2014Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2014Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2014Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
| CY2014Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2014 | |
| CY2014Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2014-03-31 | |
| CY2014Q1 | dei |
Document Type
DocumentType
|
10-Q | |
| CY2014Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000946644 | |
| CY2014Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
183853828 | shares |
| CY2014Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | |
| CY2014Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
HEMISPHERX BIOPHARMA INC |
